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Herein an inkjet-based technology as a versatile high throughput methodology for the 
microencapsulation of gold nanoparticles (AuNPs) inside a biocompatible chitosan hydrogel is 
described. This continuous automated inkjet production approach generates 30 µm diameter 
polymeric microcapsules and offers high rate of production and nanoparticle encapsulation 
efficiency of the 14 nm diameter AuNPs, precise control of the microcapsule size and ease of 
scale-up. The hybrid microcapsules demonstrate biocompatible cell-adhesion properties and 
resist degradation over a large range of pH, making them particularly relevant for a variety of 
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Microencapsulation has played centre stage in the biomedical sector for applications such as 
drug delivery, controlled release and cell/tissue targeting systems.[1] Although frequently 
employed microencapsulation techniques such as emulsions, extrusion or spray drying[2] are 
used in industrial production, these methods show several drawbacks including broad size 
distribution,[3] agglomeration of capsules or low encapsulation efficiency.[4] All of these aspects 
are of paramount importance in drug delivery systems as the rate of drug release scales with 
particle size.[5-6] Inkjet-based microsphere production technology offers the potential to 
improve such limitations to microencapsulation thanks to excellent control and reproducibility 
of particle size and efficient encapsulation.[7-8] Furthermore, from the industrial perspective, 
inkjet-based technologies represent continuous microdroplet production systems,[9-10] whereby 
the process can be fully automated. Importantly, this inkjet set-up can be easily scaled-up using 
multiple printheads working in parallel with hundreds of inkjet ejection nozzles. Practical 
aspects such as these can provide advantages for microencapsulation in a number of fields and 
industries: from the pharmaceutical industry[7-8] to biomedical applications like cell and bacteria 
microencapsulation.[11-12] 
In the biotechnology field, gold nanoparticles (AuNPs) have been used for a number of 
applications ranging from drug release[13-14] and photothermal therapy[15-16] to biosensing.[17-18] 
In principle, encapsulating nanoparticles in polymers can be employed to enhance nanoparticle 
stability, provide sustained release, enhance their bioavailability or improve other aspects 
related to their delivery and storage.[19] One of the main advantages of encapsulating AuNPs in 
polymers is that the optical properties of the AuNPs can be preserved,[20] avoiding large 
unwanted plasmon shifts due to change of solvent and plasmon hybridization.[21] Chitosan is 
one such naturally occurring biocompatible polymer that has been implemented for oral 
administration of AuNPs by protecting the nanoparticles in the gastrointestinal tract. 
Furthermore chitosan is muco-adhesive, which facilitates interaction with the intestinal 
epithelium enabling their absorption from the intestine into the bloodstream.[22-23]  
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Here we present an inkjet-based technology for the microencapsulation of gold 
nanoparticles (AuNPs) within a biocompatible polymeric hydrogel matrix (Figure 1). The 
polysaccharide chitosan (obtained by deacetylation of chitin) was used as the polymeric 
encapsulating material because of its low cytotoxicity, immunogenicity, muco-adhesive 
properties and biodegradable characteristics.[24] To the best of our knowledge, this is the first 
time that inkjet methodology has been employed successfully for microencapsulation using 
chitosan and also the first time that this technique has been used for encapsulating AuNPs. The 
benefits of employing this technology include the automatic production of polymeric 
microcapsules at a high speed and rate of production, combined with high encapsulation 
efficiency of molecules and nanoparticles in sterile conditions. Sterility is a common and crucial 
requirement for the use of hybrid materials in biotechnological applications such as oral 
delivery of anticancer cancer treatments[22] or photothermal therapy.[25]   
The inkjet microsphere production setup consists of a piezoelectric printhead equipped 
with a 50-µm nozzle (see Figure 1B-C and Figure S1). The piezoelectric element of the 
microdispenser is controlled using a multichannel device with software that enables the 
selection of an electrical waveform with defined parameters (rise, fall and pulse frequency, 
width, times and voltages). In the first instance, the stable and reproducible ejection of chitosan 
by inkjet was challenging due to tendency of chitosan to form micrometric aggregates that 
affected the ejection by obstructing the fluidics and clogging the nozzle of the inkjet 
microdispensing device. In order to avoid these issues, all reagent solutions were passed 
through a 0.45 µm filter prior to their introduction in the reservoir and a washing protocol using 
an aqueous acetic acid was used to thoroughly clean the inkjet fluidic system before and after 
each printing phase (see Supporting Information). Different electric waveforms to excite the 
piezoelectric element were studied, including trapezoidal, bipolar and tripolar, and a 
comprehensive optimization process was performed controlling all the parameters involved in 
the excitation pulse including voltage, frequency, duration of the rise and fall of the pulse(s) as 
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well as pulse width as well as other aspects such as pressure applied to the solution in the fluidic 
system. By changing the electrical pulse applied to the inkjet nozzle, a continuous ejection of 
chitosan droplets with a controlled size can be obtained, e.g. from 77 µm using trapezoidal 
down to 51 µm with tripolar (see Figure S2), all the while maintaining a stable and reproducible 
generation of droplets. This decrease in the microdroplet size is a result of the negative pressure 
induced by the voltage of the tripolar excitation.[26] For the final optimization steps, AuNPs 
were added to the ejected chitosan solution in order to avoid unwanted changes to the fluid 
properties that could negatively affect the ejection. Different chitosan concentrations were 
ejected up to a maximum concentration of 5 mg/mL, above which a stable ejection rate was 
impeded. This chitosan concentration was established as our reference and the discharge 
conditions were optimised to achieve a stable and continuous ejection for long periods of time: 
several hours at a rate of 3000 microdroplets per second at a speed of 2.4 m/s. 
Once the inkjet ejection protocol was optimised, different gelling agents to form the 
microcapsule hydrogels were tested. To facilitate the release of the drugs incorporated in the 
hydrogel in future applications, negatively charged gelling agents were employed to ionically 
cross-link the positively charged side chains of the chitosan polymer. To obtain a well-defined 
microcapsule, an almost instantaneous gelation is needed to maintain the shape of the 
microdroplets ejected when they enter in the gelling agent solution. A series of different gelling 
agents at different concentrations described in the literature, including sodium sulphate,[25] 
tripolyphosphate (TPP),[27] phosphomolybdic acid (PMA)[28] and phosphotungstic acid 
(PTA),[25] were tested by micropipetting droplets of polymer solution on a receiving solution. 
When gelling agents such as sodium sulphate and tripolyphosphate were used, they produced 
slow gelation and as a result heterogeneous amorphous hydrogel fragments were obtained (see 
Figure S3). 
Phosphotungstic acid (PTA) has been proven to serve as an efficient gelation agent for 
chitosan-based materials[28] and has demonstrated its inertness in cell culture.[25] In this inkjet 
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system the PTA proved to be an instantaneous gelling agent that enabled the formation of the 
chitosan microcapsules directly upon contact with the gelling solution. It should be noted that 
microdroplets of chitosan tend to float and form planar aggregates when they were ejected over 
PTA solution in water. To solve this drawback, the density of gelling agent was decreased by 
dissolving PTA in an ethanol-water mixture where the optimum gelling conditions were 
obtained using a 10 mg/mL PTA solution, 60 % (v/v) ethanol solution in water. Another 
advantage of using ethanol is that it ensures the sterility of microcapsules, as demonstrated by 
the absence of microorganisms studied by sterility samplers (Figure S4). Using this approach 
and adding the spherical 14 nm diameter AuNPs stabilized with carboxylic acid-terminating 
polyethylene glycol at a gold:chitosan mass ratio of 0.144 (Figure S5) to the chitosan ejection 
solution, sphere-like homogeneous AuNP-containing chitosan microcapsules were obtained 
(Figure 1D). It should be noted that a controlled agitation of gelling agent was indispensable 
to avoid aggregation and fusion of microcapsules during the gelation process. These 
microcapsules were washed with water, concentrated by decantation and their dry weight 
concentration was measured by freeze-drying (see ESI Materials and Methods). This inkjet set-
up and production methodology provided an automatic production rate of 18 mg/hour of 
microcapsules (Table 1) employing just one inkjet microdispensing device with a single nozzle. 
One of the key advantages of this system is the possibility to scale-up the production employing 
several multi-nozzle printheads performing a simultaneous ejection in parallel. 
Under the conditions reported herewithin, the monodisperse microcapsules with a mean 
diameter of 34 ± 4 µm were produced (Figure 2A-B, Figure S10). Scanning Electron 
Microscopy (SEM) and Transmission Electron Microscopy (TEM) confirmed that AuNPs were 
embedded in the chitosan hydrogel matrix (Figure 2C and S6). The amount of AuNPs 
encapsulated in the hydrogel was determined by ICP-AES, and correlated to dry the weight to 
calculate the AuNPs loading of 2.2 wt.% of gold, which represent an estimated number of 1.3 
million AuNPs per microcapsule. The proof-of-concept of our proposed microencapsulation 
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system provides >90 % encapsulation efficiency (based on the initial concentration of AuNPs 
ejected) compared to other benchtop chitosan hydrogels containing AuNPs which have shown 
far lower encapsulation efficiencies near 60%.[25] The high microencapsulation efficiency of 
this inkjet methodology could be harnessed for encapsulating expensive particles, 
pharmaceuticals or compounds that are prone to degradation, as is the case for AuNPs. In 
addition, other molecules of interest can be co-encapsulated along with the AuNPs within in 
the microcapsules by adding them to the inkjet-ejected solution. We have demonstrated this by 
the addition of the Alexa 647 fluorophore to the periphery of the microcapsules (Figure 2D-F). 
 The stability of the inkjet microcapsules in physiological and simulated fluids and in 
different buffers was studied in order to predict the feasibility of using them as potential drug 
delivery vehicles. The microcapsules possess stability over a wide range of pH displaying 
almost no liberation of AuNPs from pH 2-9, a moderate 10 % release at pH 10-11 and a 
complete degradation of the microcapsules with AuNPs releases of greater than 60 % at pH 
higher than 11 (Figure 3A). Crucially, UV-Vis spectra of the AuNPs remained unaltered after 
their release from the microcapsules (Figure S7), indicating that they maintain their colloidal 
stability without any sign of degradation or aggregation. This post-release colloidal stability is 
due to the use of –COOH terminated polyethylene glycol as surface stabilising agent for the 
AuNPs. Here the carboxylic acid PEG improves the stability of AuNPs and enables a better 
interaction with positively charged chitosan for forming the microcapsules; however, terminal 
PEG functional groups can of course also be employed for conjugating molecules of interest to 
the AuNPs.[29] This protective behavior has already been described for other chitosan-AuNPs 
hybrid systems that protected the functionality of sensitive molecules from gastric 
degradation.[23] The stability of our inkjet microcapsules was also studied by incubation in 
simulated gastric fluid that replicates the pH and ion concentration to which microcapsules 
would be exposed during a potential oral administration route. The release of AuNPs in 
simulated gastric fluids was studied after 1, 4 and 24 hours of incubation at 37 °C. Overall the 
     
7 
 
inkjet microcapsules maintained their integrity displaying only minor release of AuNPs (< 
10 %) in simulated gastric fluid under all the tested conditions after 24 hours (Figure 3B). 
As mentioned previously, the cell adhering properties in this type of hydrogel are useful 
for a wide variety of applications, such as oral delivery[19-22] and nanoparticle-mediated 
photothermal therapy.[25] Optical microscopy of the interaction between the inkjet 
microcapsules and cells showed no signs of cellular toxicity or damage (Figure S8). The 
cytotoxicity of the inkjet microcapsules was studied in vitro as a preliminary indication of safety 
for their potential applicability as drug or nanoparticle carriers. MTT cell viability assays 
showed no cytotoxicity or cell metabolism alteration after 24 hours of incubation of 
microcapsules with a HeLa cell line at concentrations up to 200 µg/mL (Figure 3C and S9). 
In conclusion, we have developed an innovative inkjet microencapsulation methodology 
for trapping nanoparticles within polymeric hydrogels. To the best of our knowledge, this is the 
first time that inkjet technology has been employed for AuNP encapsulation or for generating 
chitosan microcapsules. This novel approach enables an automatic production of microcapsules 
at a high speed and productivity, offering a high production efficiency, degree of control over 
the size of the microdroplets as well a precise control over the size and shape homogeneity of 
the corresponding microcapsules. The proof-of-concept 30-µm diameter AuNP-chitosan 
microcapsules we present show no cytotoxicity and are highly resistant to pH and to degradation 
in gastric medium. Furthermore, this preparation methodology facilitates the production of 
sterile microcapsules. This combination of attributes makes the inkjet production methodology 
highly relevant to a number of biotechnological applications where drug, compound or 
nanoparticle encapsulation, protection and delivery play key roles for the development of 
functional materials. 
 
Supporting Information  
Supporting Information is available below. 
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Figure 1. A) Scheme of the inkjet-based methodology employed for AuNP encapsulation in 
chitosan hydrogel by the production of microdroplets of AuNPs and chitosan solution, using a 
piezoelectric inkjet printhead. The microcapsules are formed by instantaneous ionic gelation 
when they enter into contact with the gelling agent phosphotungstic acid (PTA). B) Inkjet 
system employed for the microdroplet generation. C) Photograph of the chitosan and AuNPs 
droplets ejected from the inkjet printhead at a rate of 3000 microdroplets per second. D) Optical 









Figure 2. A) Optical contrast-phase microscopy image of chitosan microcapsules containing 
the AuNPs in aqueous media. B) Size distribution histogram calculated from the measurements 
taken from brightfield microscopy images. C) Transmission Electron Microscopy image of the 
hydrogel structure of the microcapsules containing the AuNPs. D) 3D reconstruction of the 
structure of the microcapsules from the florophore images obtained with the confocal 
microscopy. E-F) Confocal microscopy image of the microcapsules containing the AuNPs and 
the fluorophore Alexa 647. The fluorophore is shown in blue in the overlay of the fluorescence 
and the bright field channels (E) and in the fluorescence cannel (F). It can be appreciated that 
the Alexa 647 fluorophore is encapsulated in the external part of the microcapsules produced 









Figure 3. A) pH-dependent release of AuNPs from microcapsules measured after 24 hours of 
incubation. B) AuNPs release in water and in simulated gastric fluids at different incubation 
times of 1, 4 and 24 hours. C) HeLa cell viability test by MTT of the microcapsules containing 
the AuNPs incubated at different concentrations for 24 hours, showing no sign of toxicity. 
 










Characteristics of AuNP microencapsulation by inkjet 
Encapsulation efficiency (%) 92.4 ± 5.8 
Gold loading (% Au/dry weight) 2.2 ± 0.1 
Rate of production (mg/h) 18 
Frequency (microcapsules/s) 3000 
Size (µm) 34 ± 4 
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1. Materials and equipment 
 
1.1. Reagents  
 
The reagents used in this study were purchased from Merck KGaA, Darmstadt, Germany, 
unless otherwise specified. Hydrogen tetrachloroaurate (III) hydrate (HAuCl4) was purchased 
from Strem Chemicals. Alpha-Thio-omega-(propionic acid) octa(ethylene glycol) (HS- PEG-
COOH) (458 g/mol) and was purchased from Iris Biotech GmbH.  Chitosan of low molecular 
weight (50-190 KDa) was purchased from Merck Complete Dulbeccos’s modified Eagle’s 
medium (DMEM), phosphate buffered saline (PBS) and Dulbecco’s Phosphate Buffered Saline 
(DPBS) supplemented with Ca2+ and Mg2+ were purchased from Lonza R (Basel, Switzerland). 
Prior to use, all glassware was washed with aqua regia and rinsed thoroughly with Milli-Q 
water from Millipore Q-POD® system. DMEM was supplemented with 2mM glutamine, 100 
U/mL penicillin/streptomycin, and 10 % foetal bovine serum (FBS) for its use in cell culture. 
For the cell viability assays, MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide) was purchased from InvitrogenTM (CA, USA). Alexa Fluor 647 alkyne was purchased 
from Thermofisher Scientific. Coli-Count™ Sampler (Ref. MC0010025), HPC Total Count 
Sampler (Ref. MHPC10025) and Yeast and Mould Sampler (Ref. MY0010025) were purchased 
from Merck (Germany). 
 
1.2. Equipment details 
 
UV-Vis-NIR spectra were acquired using a Cary 50 Probe® spectrophotometer from Varian 
(TO, Italy). For ICP elemental analysis, samples were evaluated by ICP–Atomic emission 
spectroscopy (AES) using Optima 8300 (Perkin Elmer®, MA, USA). SEM images were 
collected using a field emission SEM Inspect F50 with an EDX system INCA PentaFETx3 (FEI 
Company, Eindhoven, The Netherlands) in an energy range between 0-30 keV. TEM images 
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were collected using a FEI Tecnai TF20 (FEI Europe, Eindhoven, Netherlands) working at 200 
kV. Samples were freeze-dried in a Telstar cryodos freeze-dryer (Spain) with an Agilent 
technologies DS 102 vacuum pump. Confocal microscopy images were acquired employing a 
Zeiss LSM 880 confocal microscope with an objective 63X, zoom 1.0 and laser source of 633 
nm. 
 
1.3.  Inkjet set up 
 
The inkjet based microsphere production setup relies on a piezoelectric printhead MJ-ABP-01-
50 from Microfab Technologies, Inc with a nozzle of 50 µm. The piezoelectric element of the 
microdispenser is addressed by using a multichannel JetDrive III device (CT-MC3-4) also from 
Microfab. Software associated (JetSererTM, Microfab) enables the selection of an electrical 
waveform (8 point bipolar trapezoidal waveforms) with well-defined waveform parameters 
(rise, fall and pulse width, frequency, times and voltages). Pressure and vacuum to control the 
inkjet dispenser is provided by a CT-PT-4 (Microfab). The software and electronics also 
controls the strobe LED and the acquisition of the camera to observe the droplet formation 
process (see Figure 1 and Figure S1 for more details). All the solutions were filtered with 




2.1. Gold nanoparticle preparation and characterization 
 
Gold nanospheres (AuNPs) with a diameter of 14 nm and a maximum absorbance peak (LSPR) 
at 523 nm, were prepared as previously described with minor  using the Frens-citrate approach 
and then coated with HS-PEG-COOH of 458 Da applying the previously reported methodology 
with minor modifications.[29-30] Briefly, 195 mL of tetrachloroauric acid (HAuCl4) at 1.2 mM 
was heated until boiling and 5 mL of sodium citrate at 162 mM were added and remained 
boiling for 30 minutes, light-protected. After that, 10 nM bare gold nanospheres (calculated 
from ICP-AES quantification) were mixed with 0.028 % sodium dodecyl sulphate, 50 µM HS-
PEG-COOH and NaOH 25 mM and incubated for 16 hours in agitation at room temperature. 
The nanoparticles were washed 3 times by centrifugation for 30 min at 18000 rcf and 4 °C. The 
pellet of nanoparticles was resuspended in ultrapure water and stored at 4 °C. Extinction 
coefficient (11.3 mL·mg-1·cm-1) was calculated correlating their UV-vis absorbance at 450 nm 
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with the gold content measured by ICP-AES. The molecular weight of AuNPs was calculated 
from the diameter of nanoparticles measured from TEM images and the gold density value 
(19.3 g·cm-3).  
 
2.2. Microencapsulation of AuNPs by Inkjet printing 
 
After a carefully optimization of the system parameters, the most consistent ejection was 
obtained employing the following experimental conditions. 1 mL of chitosan at 10 mg/mL in 
acetic acid 1 % was mixed with 400 µL of acetic acid 10 % (aq.) and 600 µL of AuNS at 2.4 
mg/mL. All the solutions were filtered with filters of 0.45 µm (Millex-HV REF SLHV033RS) 
before been ejected using the inkjet system. This solution was ejected employing monopolar 
electric pulse with a rise time of 3 µs, a dwell time of 15 µs and a fall time of 3 µs, a dwell 
voltage of 32 V and at a frequency of 3000 Hz. The microdroplets ejected with the inkjet over 
20 mL of gelling agent solution composed by PTA at 10 mg/mL in 60 % (vol/vol) ethanol (aq.) 
in mild magnetic stirrer agitation. It was important to carefully wash the inkjet system after the 
ejection employing 3 volumes of acetic acid 1 % (aq.) in order to avoid future blocking 
problems due to chitosan residues. After that, the microcapsules were washed 3 times with 10 
mL of Milli-Q water by 1 hour of decantation in sterile conditions. 
 
2.3. Characterization of chitosan microcapsules 
 
The concentration of the microcapsules in dry weight was calculated by measuring the weight 
of 0.2 mL of sample after freeze-drying. The morphology and size of the microcapsules was 
measured from photographs taken from optical brightfield microscopy images. In order to study 
the structure and the position of AuNPs inside the hydrogel, the microcapsules were diluted to 
0.5 mg/mL in water and 2 µL were deposited on the grid (Ref. CF200-Cu, Electron Microscopy 
Science), dried at room temperature and analysed in detail by transmission electron microscopy 
(TEM) and scanning electron microscopy (SEM). 
For the co-encapsulation study employing the fluorophore Alexa Fluor 647 Alkyne the 
microcapsules were produced as previously described just adding Alexa 647 at a final 
concentration of 10 µg/mL to the ejection solution. The microcapsules produced by this 
methodology were characterised in solution by confocal microscopy imaging employing a Zeiss 
LSM 880 confocal microscope with an objective 63X, zoom 1.0 and laser source of 633 nm. 
The 3D reconstruction was performed using the software Zen Blue 2.3 Lite.  
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The gold content inside the hydrogel was quantified by inductively coupled plasma 
atomic emission spectroscopy (ICP-AES). 100 µL of the sample were previously digested by 
addition of 100 µL of a 3:1 sulfuric acid (96 %)/hydrogen peroxide (33 %) solution and 
incubated 15 min at room temperature. After that, 300 µL of a 1:3 nitric acid 
(65 %)/hydrochloric acid (37 %) solution were added. After incubation for 2 h at room 
temperature the samples were heated to 60 °C for 15 min and they were finally diluted with 
Milli-Q water up to 20 mL. All samples were prepared and analysed by triplicate. The number 
of gold nanoparticles per microcapsule was estimated from the frequency of production (3000 
microcapsules/s), the reaction production (18 mg/mL) the drug loading (2.2 %) and the 
molecular weight of AuNP (1.67*107 g/mol). 
The sterility tests were performed according to the supplier instructions, analysing the 
presence of several microorganisms. The presence of coliform organisms was tested using the 
Coli-Count™ Sampler, the presence of aerobic bacteria using HPC Total Count Sampler and 
the presence of yeast or moulds employing the Yeast and Mould Sampler. In detail, the Sampler 
case was filled with 18 mL of sterile water and 100 µL of sample were added, the Sampler was 
inserted into the case and maintained in contact with the sample for 30 seconds. After that, the 
liquid was discarded, the Sampler was reinserted and it was incubated for 48 h at 32 °C for 
Yeast and Mould, 48 h at 35 °C HPC Total Count and 24 h at 35 °C for Coli-Count™ Sampler.  
 
2.4. AuNPs release from chitosan microcapsules 
 
To study the release of the AuNPs, the microcapsules were incubated with different media. For 
the pH resistance assay the microcapsules were incubated with sodium phosphate 10 mM at 
different pHs (2-12). For the oral delivery simulation, simulated gastric medium was employed 
(NaCl at 34.2 mM at a pH of 1.76).[31] The microcapsules were diluted in the different media 
until 200 µg/mL in a total volume of 500 µL and were incubated at 37 ℃ with incubation for 1, 
4 and 24 hours. After that the microcapsules were centrifuged at 3000 rpm for 5 min in a 
centrifuge MiniSpin plus and 300 µL were collected for their analysis by UV-Vis spectroscopy 
and ICP-AES. Experiments were performed in triplicate. 
 
2.5. Biocompatibility of chitosan microcapsules 
 
All in vitro studies were performed using HeLa cell line, acquired from Amsbio (Ref. SC034-
Puro). Cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM) supplemented 
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with 10 % foetal bovine serum (FBS), 2 mM glutamine, and 100 U/mL penicillin/streptomycin 
at 37 °C, 5 % CO2 atmosphere. 
For the MTT assays, 2.5 × 103 HeLa cells per well were seeded in a 96-multiwell plate 
and the day after they were incubated with each of the concentrations of the biomaterials for 24 
h. At this point, cells were washed 2 times with 200 µL of DPBS and 200 µL of DMEM 
containing 10 µL of 5 mg/mL MTT were added and they were incubated under culture 
conditions for 90 min in the dark. Finally, the plate was centrifuged at 1,250 g for 30 min using 
an Eppendorf centrifuge 5810R with an A-4-62 rotor, the supernatant was removed and the 
formazan crystals were solubilized with 100 µL of dimethyl sulfoxide (DMSO). After mixing, 
the optical density at 555 nm was recorded using a plate reader. Experiments were performed 
in quintuplet and compared with blanks of cells incubated with the microcapsules but without 
addition of MTT. 




Figure S1. Inkjet system employed for the microdroplet generation, with optical system to 
monitor the microdroplet ejection.   
 




Figure S2. Photographs of inkjet ejection of chitosan 0.1 % (aq.) controlling the size of the 
microdroplet just by employing different electric pulse waveforms. In this way, it was 
possible to reduce the size from 77 µm using a trapezoidal waveform to 51 µm using a 





Figure S3. Contrast phase microscopy image of microcapsules synthesised employing PTA 
(A) or tripolyphosphate (B) as gelling agent.  





Figure S4. Photographs of sterility testers analysing the presence of microorganisms, 
comparing a negative control (sterile water), two different batches of microcapsules with 
AuNPs (microcapsules 1 and 2) and a positive control of contamination (ground sample). 
Coliform organisms were tested using the Coli-Count™ Sampler (blue), aerobic bacteria using 
HPC Total Count Sampler (red) and yeast or moulds employing the Yeast and Mould Sampler 
(yellow). 
 




Figure S5. Gold nanoparticle (AuNPs) characterization by TEM (A) and UV-Vis spectroscopy 
(B) showing the monodispersity, size morphology and localized surface plasmon resonance 





Figure S6. Scanning electron microscopy (SEM) of the microcapsules, showing a complete 










Figure S7. UV-Vis absorbance spectra of AuNPs comparing the AuNPs released from the 
microcapsules after exposure to pH 12 (Released AuNPs) with the AuNPs before their inkjet 
microencapsulation (Original AuNPs) along with the AuNPs when encapsulated within the 
chitosan microcapsules (Microencapsulated AuNPs). It can be seen how the AuNP spectrum 
after release remains identical to the original AuNPs, indicating the stability of the AuNPs 




Figure S8. Microscopy images of HeLa cells incubated for 24 hours with 0 (A), 50 (B), 100 
(C) and 200 (D) µg/mL of microcapsules. 
 





Figure S9. A) Microscopy image of HeLa cells incubated for 24 hours with the microcapsules 
after the MTT assay. B) Absorbance UV-Vis spectra of the cells incubated with the 
microcapsules treated or not treated with MTT, showing a negligible interference of the 





Figure S10. A selection of phase contrast microscopy images of microcapsules employed for 
histogram distribution in Figure 2B. All scale bars correspond to 50 µm. 
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